View in EDS

Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration study.

Saved in:

Bibliographic Details
Title:	Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration study.
Authors:	Aubrey RE; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Psarianos P; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Santiago AT; Department of Biostatistics, University Health Network, Toronto, Ontario, Canada., Griffin AM; Division of Orthopaedic Surgery, Department of Surgery, Sinai Health System, Toronto, Ontario, Canada., Ferguson PC; Division of Orthopaedic Surgery, Department of Surgery, Sinai Health System, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada., Gupta AA; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada., Peretz Soroka H; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Shultz DB; University of Toronto, Toronto, Ontario, Canada.; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Source:	Cancer [Cancer] 2026 Feb 01; Vol. 132 (3), pp. e70263.
Publication Type:	Journal Article
Journal Info:	Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1097-0142
DOI:	10.1002/cncr.70263